Boston Scientific 8-K

NegativeCybersecurity incidentGuidance deferred to the call

Cybersecurity incident disrupted global networks, manufacturing and order shipments, making Q3 and FY2026 sales growth and adjusted EPS guidance unlikely to be met.

Filed 2026-09-08 06:15 ET

Alerts

Filing event

  • Cybersecurity incident

    This filing includes Item 1.05. The company has judged a cybersecurity incident material; see the filing for what is known of its scope and impact.

An alert from the filing's SEC item codes, not from reading its text. Filing on SEC.gov

Summary

Cybersecurity incident disrupting operations, with a likely material impact on Q3 and FY2026 results. Unauthorized activity identified on 8/25/2026 caused a global network outage that disrupted manufacturing and the processing and shipping of customer orders. Boston Scientific says it is unlikely to meet its previously issued Q3 and FY2026 net sales growth and adjusted EPS guidance. Recovery is progressing, but the timeline for full operational recovery remains uncertain; the company does not expect a material impact on long-term financial condition.

Guidance

Guidance to be given on the earnings call.

Investor Takeaways

  • Watch the 10/28/2026 conference call for an updated operational and financial outlook for the remainder of FY2026.
  • The pace of full system recovery, manufacturing ramp-up and backlog reduction will determine how much impacted revenue the company can recover.

The summary is written by an AI model reading the filing.

Model 005 · prompt 01d34d48e3

Feedback